Experts in the management of migraine discuss the prevalence of individuals taking acute migraine therapy and enumerate the various classes of agents available.
A discussion on the differences between acute and preventive migraine treatment, and the impact of treatment on quality of life.
April 22nd 2021, 12:45pm
Research presented at the American Academy of Neurology's annual meeting indicates some air pollutants may be associated with increased rates of migraine prevalence and severity.
April 19th 2021, 9:05pm
Data from a single health system show women who present to the emergency department for headache tend to do so during the preovulatory interval of their menstrual cycle.
April 13th 2021, 7:45pm
Results of a questionnaire-based study show higher body mass index (BMI) is associated with worse migraine symptoms and comorbidities.
April 12th 2021, 3:42pm
Results from a questionnaire-based study indicated an association between a history of abuse and increased sensory hypersensitivity symptoms among migraineurs.
April 7th 2021, 1:00pm
A review published in Neuropsychiatric Disease and Treatment highlights the lack of research on migraine prevalence and symptoms among postmenopausal women.
April 1st 2021, 5:38pm
Researchers used deidentified real-world data to assess characteristics of patients who have received erenumab since its approval.
March 30th 2021, 6:51pm
A cross-sectional study explores the relationship between magnesium, calcium dietary intake, and migraine among men and women.
March 23rd 2021, 4:41pm
Randomized clinical trial results published in Cephalalgia show that trans-nasal high-flow dry gas therapy may play a role in reducing migraine-associated pain.
March 22nd 2021, 5:15pm
Compared with healthy controls, patients with episodic migraine and patients with chronic migraine exhibited differing structural brain network characteristics, potentially indicating maladaptive reorganizations of headache-related brain circuits which could lead to migraine attacks or secondary alterations to pain.
March 17th 2021, 4:30pm
Results of a scoping review of 19 studies indicate estrogen likely plays a key role in migraine pathogenesis but affects patients in different ways depending on past medical history, age, and use of hormonal therapy.